Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus

New England Journal of Medicine

Volumn 339, Issue 20, 1998, Pages 1409-1414

  Wade, Nancy A ^a   Birkhead, Guthrie S ^a,c   Warren, Barbara L ^a   Charbonneau, Tina T ^b   French, P Tyler ^a   Wang, Ling ^a   Baum, Jeanne B ^a   Tesoriero, James M ^a   Savicki, Robert ^a  

^a NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^b WADSWORTH CENTER   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; DEMOGRAPHY; DISEASE TRANSMISSION; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PRENATAL CARE; PRIORITY JOURNAL; SCREENING TEST; SEROPREVALENCE; TREATMENT OUTCOME; UNITED STATES;

ANTI-HIV AGENTS; CLINICAL PROTOCOLS; COHORT STUDIES; DISEASE TRANSMISSION, VERTICAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; NEW YORK; POLYMERASE CHAIN REACTION; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; RETROSPECTIVE STUDIES; RISK; ZIDOVUDINE;

EID: 0032511952     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199811123392001     Document Type: Article

References (20)

1. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173-80.
2. Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 1994;43(RR-11):1-20.
3. Public Health Service Task Force recommendations for the use of anti-retroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. MMWR Morb Mortal Wkly Rep 1998;47(RR-2):1-30.
4. U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR Morb Mortal Wkly Rep 1995;44(RR-7):1-15.
5. Provisional Committee on Pediatric AIDS, American Academy of Pediatrics. Perinatal human immunodeficiency virus testing. Pediatrics 1995; 95:303-7.
6. Human immunodeficiency virus infections in pregnancy. Int J Gynecol Obstet 1997;57:73-80.
7. N.Y. Comp. Codes R. & Regs. tit. 10, §§ 98.2(c), 405.21 (c)(8)(h), 751.5 (a)(16) and 754.7 (c)(3) (1996).
8. Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission - Thailand, 1996-1998. MMWR Morb Mortal Wkly Rep 1998;47:151-4.
9. Charbonneau TT, Wade NA, Weiner L, et al. Vertical transmission of HIV in New York State: a basis for statewide testing of newborns. AIDS Patient Care STDs 1997;11:227-36.
10. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
11. Cornfield J, Gordon T, Smith WW. Quantal response curves for experimentally uncontrolled variables. Bull Inst Int Stat 1961;38:97-115.
12. Walker SH, Duncan DB. Estimation of the probability of an event as a function of several independent variables. Biometrika 1967;54:167-79.
13. SAS, version 6.11. Cary, N.C.: SAS Institute, 1995.
14. Fiscus SA, Aldimora AA, Schoenbach VJ, et al. Importance of maternal zidovudine therapy in the reduction of perinatal transmission of HIV. In: Program and abstracts of the Fourth Conference on Retroviruses and Opportunistic Infections, Washington, D.C., January 22-26, 1997:134. abstract.
15. Cooper ER, Nugent RP, Diaz C, et al. After AIDS Clinical Trial 076: the changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. J Infect Dis 1996; 174:1207-11.
16. Van Rompay KKA, Otsyula MG, Marthas ML, Miller CJ, McChesney MB, Pedersen NC. Immediate zidovudine treatment protects simian immunodeficiency virus-infected newborn macaques against rapid onset of AIDS. Antimicrob Agents Chemother 1995;39:125-31.
17. Tsai CC, Follis KE, Sabo A, et al. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine. Science 1995; 270:1197-9.
18. Bottiger D, Johansson NG, Samuelsson B, et al. Prevention of simian immunodeficiency virus, SIVsm, or HIV-2 infection in cynomolgus monkeys by pre- and postexposure administration of BEA-005. AIDS 1997;11:157-62.
19. Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood - France, United Kingdom, and United States, January 1988-August 1994. MMWR Morb Mortal Wkly Rep 1995;44:929-33.
20. Update: HIV counseling and testing using rapid tests - United States, 1995. MMWR Morb Mortal Wkly Rep 1998;47:211-5.